Format
Sort by
Items per page

Send to

Choose Destination

Links from PubMed

Items: 1 to 20 of 121

1.

Androgen-dependent impairment of myogenesis in spinal and bulbar muscular atrophy.

Malena A, Pennuto M, Tezze C, Querin G, D'Ascenzo C, Silani V, Cenacchi G, Scaramozza A, Romito S, Morandi L, Pegoraro E, Russell AP, SorarĂ¹ G, Vergani L.

Acta Neuropathol. 2013 Jul;126(1):109-21. doi: 10.1007/s00401-013-1122-9. Epub 2013 May 4.

PMID:
23644820
2.

Enhanced aggregation of androgen receptor in induced pluripotent stem cell-derived neurons from spinal and bulbar muscular atrophy.

Nihei Y, Ito D, Okada Y, Akamatsu W, Yagi T, Yoshizaki T, Okano H, Suzuki N.

J Biol Chem. 2013 Mar 22;288(12):8043-52. doi: 10.1074/jbc.M112.408211. Epub 2013 Jan 30.

3.

Spinal and bulbar muscular atrophy: ligand-dependent pathogenesis and therapeutic perspectives.

Katsuno M, Adachi H, Tanaka F, Sobue G.

J Mol Med (Berl). 2004 May;82(5):298-307. Epub 2004 Feb 27. Review.

PMID:
15133611
4.

Loss of endogenous androgen receptor protein accelerates motor neuron degeneration and accentuates androgen insensitivity in a mouse model of X-linked spinal and bulbar muscular atrophy.

Thomas PS Jr, Fraley GS, Damian V, Woodke LB, Zapata F, Sopher BL, Plymate SR, La Spada AR.

Hum Mol Genet. 2006 Jul 15;15(14):2225-38. Epub 2006 Jun 13. Erratum in: Hum Mol Genet. 2006 Oct 1;15(19):2972. Damien, Vincent [corrected to Damian, Vincent].

PMID:
16772330
5.

Inhibition of the Androgen Receptor by Antiandrogens in Spinobulbar Muscle Atrophy.

Baniahmad A.

J Mol Neurosci. 2016 Mar;58(3):343-7. doi: 10.1007/s12031-015-0681-8. Epub 2015 Nov 12. Review.

PMID:
26563449
6.

Transgenic mouse models of spinal and bulbar muscular atrophy (SBMA).

Katsuno M, Adachi H, Inukai A, Sobue G.

Cytogenet Genome Res. 2003;100(1-4):243-51. Review.

PMID:
14526186
7.
8.

Antiandrogen flutamide protects male mice from androgen-dependent toxicity in three models of spinal bulbar muscular atrophy.

Renier KJ, Troxell-Smith SM, Johansen JA, Katsuno M, Adachi H, Sobue G, Chua JP, Sun Kim H, Lieberman AP, Breedlove SM, Jordan CL.

Endocrinology. 2014 Jul;155(7):2624-34. doi: 10.1210/en.2013-1756. Epub 2014 Apr 17.

9.

Aberrant E2F activation by polyglutamine expansion of androgen receptor in SBMA neurotoxicity.

Suzuki E, Zhao Y, Ito S, Sawatsubashi S, Murata T, Furutani T, Shirode Y, Yamagata K, Tanabe M, Kimura S, Ueda T, Fujiyama S, Lim J, Matsukawa H, Kouzmenko AP, Aigaki T, Tabata T, Takeyama K, Kato S.

Proc Natl Acad Sci U S A. 2009 Mar 10;106(10):3818-22. doi: 10.1073/pnas.0809819106. Epub 2009 Feb 23. Erratum in: Proc Natl Acad Sci U S A. 2012 Oct 2;109(40):16393.

10.

Cytoplasmic retention of polyglutamine-expanded androgen receptor ameliorates disease via autophagy in a mouse model of spinal and bulbar muscular atrophy.

Montie HL, Cho MS, Holder L, Liu Y, Tsvetkov AS, Finkbeiner S, Merry DE.

Hum Mol Genet. 2009 Jun 1;18(11):1937-50. doi: 10.1093/hmg/ddp115. Epub 2009 Mar 11.

11.

Mechanisms mediating spinal and bulbar muscular atrophy: investigations into polyglutamine-expanded androgen receptor function and dysfunction.

Beitel LK, Alvarado C, Mokhtar S, Paliouras M, Trifiro M.

Front Neurol. 2013 May 15;4:53. doi: 10.3389/fneur.2013.00053. eCollection 2013.

12.

New routes to therapy for spinal and bulbar muscular atrophy.

Rocchi A, Pennuto M.

J Mol Neurosci. 2013 Jul;50(3):514-23. doi: 10.1007/s12031-013-9978-7. Epub 2013 Feb 19. Review.

PMID:
23420040
13.

Pathogenesis and molecular targeted therapy of spinal and bulbar muscular atrophy.

Adachi H, Waza M, Katsuno M, Tanaka F, Doyu M, Sobue G.

Neuropathol Appl Neurobiol. 2007 Apr;33(2):135-51. Review.

PMID:
17359355
14.

Increased mitophagy in the skeletal muscle of spinal and bulbar muscular atrophy patients.

Borgia D, Malena A, Spinazzi M, Desbats MA, Salviati L, Russell AP, Miotto G, Tosatto L, Pegoraro E, SorarĂ¹ G, Pennuto M, Vergani L.

Hum Mol Genet. 2017 Mar 15;26(6):1087-1103. doi: 10.1093/hmg/ddx019.

15.

Spinal and bulbar muscular atrophy: skeletal muscle pathology in male patients and heterozygous females.

SorarĂ¹ G, D'Ascenzo C, Polo A, Palmieri A, Baggio L, Vergani L, Gellera C, Moretto G, Pegoraro E, Angelini C.

J Neurol Sci. 2008 Jan 15;264(1-2):100-5. Epub 2007 Sep 12.

PMID:
17854832
16.
17.

An interdomain interaction of the androgen receptor is required for its aggregation and toxicity in spinal and bulbar muscular atrophy.

Orr CR, Montie HL, Liu Y, Bolzoni E, Jenkins SC, Wilson EM, Joseph JD, McDonnell DP, Merry DE.

J Biol Chem. 2010 Nov 12;285(46):35567-77. doi: 10.1074/jbc.M110.146845. Epub 2010 Sep 8.

18.

Neuropathology and therapeutic intervention in spinal and bulbar muscular atrophy.

Banno H, Katsuno M, Suzuki K, Tanaka F, Sobue G.

Int J Mol Sci. 2009 Mar;10(3):1000-12. Epub 2009 Mar 10. Review.

19.

Androgens inhibit androgen receptor promoter activation in motor neurons.

Vismara G, Simonini F, Onesto E, Bignamini M, Miceli V, Martini L, Poletti A.

Neurobiol Dis. 2009 Mar;33(3):395-404. doi: 10.1016/j.nbd.2008.11.007. Epub 2008 Dec 6.

PMID:
19100835
20.

Pathogenesis and therapy of spinal and bulbar muscular atrophy (SBMA).

Katsuno M, Tanaka F, Adachi H, Banno H, Suzuki K, Watanabe H, Sobue G.

Prog Neurobiol. 2012 Dec;99(3):246-56. doi: 10.1016/j.pneurobio.2012.05.007. Epub 2012 May 15. Review.

PMID:
22609045

Supplemental Content

Support Center